MDM4
Protein Mdm4
Also known as: HDMX, MDM4_HUMAN, MDMX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15151
- Gene
- MDM4
- Ensembl
- ENSG00000198625
- Chromosome
- 1
- Canonical length
- 490 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a nuclear protein that contains a p53 binding domain at the N-terminus and a RING finger domain at the C-terminus, and shows structural similarity to p53-binding protein MDM2. Both proteins bind the p53 tumor suppressor protein and inhibit its activity, and have been shown to be overexpressed in a variety of human cancers. However, unlike MDM2 which degrades p53, this protein inhibits p53 by binding its transcriptional activation domain. This protein also interacts with MDM2 protein via the RING finger domain, and inhibits the latter's degradation. So this protein can reverse MDM2-targeted degradation of p53, while maintaining suppression of p53 transactivation and apoptotic functions. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
490 residues, UniProt reviewed canonical sequence.
>O15151|MDM4
1 MTSFSTSAQC STSDSACRIS PGQINQVRPK LPLLKILHAA GAQGEMFTVK EVMHYLGQYI
61 MVKQLYDQQE QHMVYCGGDL LGELLGRQSF SVKDPSPLYD MLRKNLVTLA TATTDAAQTL
121 ALAQDHSMDI PSQDQLKQSA EESSTSRKRT TEDDIPTLPT SEHKCIHSRE DEDLIENLAQ
181 DETSRLDLGF EEWDVAGLPW WFLGNLRSNY TPRSNGSTDL QTNQDVGTAI VSDTTDDLWF
241 LNESVSEQLG VGIKVEAADT EQTSEEVGKV SDKKVIEVGK NDDLEDSKSL SDDTDVEVTS
301 EDEWQCTECK KFNSPSKRYC FRCWALRKDW YSDCSKLTHS LSTSDITAIP EKENEGNDVP
361 DCRRTISAPV VRPKDAYIKK ENSKLFDPCN SVEFLDLAHS SESQETISSM GEQLDNLSEQ
421 RTDTENMEDC QNLLKPCSLC EKRPRDGNII HGRTGHLVTC FHCARRLKKA GASCPICKKE
481 IQLVIKVFIALocalizationUniProt · AlphaFold · HPA
Whether an antibody against MDM4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 51 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 51 nTPM
- thymus: 28 nTPM
- retina: 23 nTPM
- spleen: 21 nTPM
- skin: 19 nTPM
- testis: 19 nTPM
Single-cell type
- neutrophils: 353 nCPM
- choroid plexus epithelial cells: 283 nCPM
- late spermatids: 255 nCPM
- sertoli cells: 252 nCPM
- b-cells: 247 nCPM
- microglia: 243 nCPM
Immune cell
- basophil: 4.1 nTPM
- eosinophil: 3.6 nTPM
- neutrophil: 3.6 nTPM
- naive B-cell: 3.3 nTPM
- plasmacytoid DC: 3.1 nTPM
- memory B-cell: 2.8 nTPM
Brain region
- choroid plexus: 106 nTPM
- white matter: 102 nTPM
- thalamus: 69 nTPM
- basal ganglia: 69 nTPM
- medulla oblongata: 69 nTPM
- hypothalamus: 68 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MDM4.
Disease | AllUniProt
Conditions MDM4 is implicated in, by any mechanism.
- Bone marrow failure syndrome 6 (BMFS6) MIM:618849
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.11
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.71
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- atrial septum development
- atrioventricular valve morphogenesis
- cellular response to hypoxia
- DNA damage response, signal transduction by p53 class mediator
- endocardial cushion morphogenesis
- heart valve development
- negative regulation of apoptotic process
- negative regulation of cell population proliferation
- negative regulation of DNA-templated transcription
- negative regulation of protein catabolic process
- negative regulation of signal transduction by p53 class mediator
- negative regulation of transcription by RNA polymerase II
- protein stabilization
- protein ubiquitination
- protein-containing complex assembly
- regulation of cell cycle
- ventricular septum development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MDM4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MDM4 as an antibody target. Whether an autoantibody or antibody against MDM4 could matter depends on whether native MDM4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MDM4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MDM4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...